SCHEMBL6038182

SCHEMBL6038182

COc1ccc(NS(=O)(=O)c2ccc(CCN)cc2)cc1OC

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.68
HTT P42858 3/20 0.68
SMN1; SMN2 Q16637 2/20 0.68
HTR6 P50406 2/20 0.64
ALOX15 P16050 1/20 0.61
MAPK1 P28482 1/20 0.61
HDAC1 Q13547 2/20 0.55
TSHR P16473 2/20 0.55
NPSR1 Q6W5P4 2/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
ALDH1A1 P00352 2/20 0.55
PKM P14618 1/20 0.55
KDM4E B2RXH2 1/20 0.55
ATM Q13315 1/20 0.55
HDAC4 P56524 1/20 0.54
CA12 O43570 1/20 0.53
CA9 Q16790 1/20 0.53
NPC1 O15118 1/20 0.52
NR2F2 P24468 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6038095 0.84 LMNA (0.64) LMNAHTTSMN1; SMN2ALOX15MAPK1
SCHEMBL30532978 0.80 LMNA (0.79) LMNAHTTSMN1; SMN2ALOX15MAPK1
SCHEMBL29048773 0.80 LMNA (0.79) LMNAHTTSMN1; SMN2ALOX15MAPK1
SCHEMBL6795551 0.79 LMNA (0.77) LMNAHTTSMN1; SMN2ALOX15MAPK1
SCHEMBL6037954 0.79 LMNA (0.77) LMNAHTTSMN1; SMN2HTR6ALOX15
SCHEMBL213547 0.79 LMNA (0.77) LMNAHTTSMN1; SMN2HTR6ALOX15
SCHEMBL399122 0.79 LMNA (0.77) LMNAHTTSMN1; SMN2HTR6ALOX15
SCHEMBL6038125 0.78 LMNA (0.55) LMNAHTTSMN1; SMN2HTR6ALOX15
SCHEMBL7258961 0.77 HTR6 (0.72) LMNAHTR6MAPK1MEN1KMT2A
SCHEMBL10144016 0.76 LMNA (0.82) LMNAHTTSMN1; SMN2ALOX15MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264415-A1 Inhibitors of histone deacetylase METHYLGENE INC. 2006-11-23 US disclosed
WO-2006102760-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2006-10-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264415-A1 Inhibitors of histone deacetylase HDAC1, HDAC3, HDAC11 LMNA 851/4885HTT 846/4885SMN1; SMN2 3733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.